tm logo
PONTEFINA
Live/Registered
REGISTERED

on 21 May 2024

Last Applicant/ Owned by

2969 N DIXIE HWY APT 632

OAKLAND PARK

FL

33334

Serial Number

97654034 filed on 29th Oct 2022

Registration Number

7393056 registered on 21st May 2024

in the Principal Register

Correspondent Address

RUBEN ALCOBA

RUBEN ALCOBA ALCOBA LAW GROUP PA

DORAL, FL 33166

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PONTEFINA

Medicaments for fungal, bacterial, viral infections, and other conditions and disorders, namely, athlete's foot, bedsores, burns, cold sores, fever blisters, dermatitis, diabetic ulcers, diaper rash, eczema, foot and leg ulcers, hemorrhoids, itch and rash, molluscum, poison ivy, oak and sumac, pressure sores, psoriasis, ringworm, rosacea, seborrheic dermatitis, shingles, skin infections, sunburn, Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicaments for fungal, bacterial, viral infections, and other conditions and disorders, namely, athlete's foot, bedsores, burns, cold sores, fever blisters, dermatitis, diabetic ulcers, diaper rash, eczema, foot and leg ulcers, hemorrhoids, itch and rash, molluscum, poison ivy, oak and sumac, pressure sores, psoriasis, ringworm, rosacea, seborrheic dermatitis, shingles, skin infections, sunburn, tinea versicolor, warts, wounds, damaged skin and tissue


First Use Date in General

13th Mar 2024

First Use Date in Commerce

13th Mar 2024

Mark Details


Serial Number

No 97654034

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
21st May 2024REGISTERED-PRINCIPAL REGISTER
16th Apr 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Apr 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03rd Apr 2024STATEMENT OF USE PROCESSING COMPLETE
03rd Apr 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
13th Mar 2024TEAS STATEMENT OF USE RECEIVED
13th Mar 2024USE AMENDMENT FILED
21st Nov 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26th Sep 2023PUBLISHED FOR OPPOSITION